Xlife Sciences AG
F:XLS
Xlife Sciences AG
F:XLS
Price:
16.6
EUR
-2.35%
Market Closed
Market Cap:
€95.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Xlife Sciences AG
F:XLS
|
CH |
|
Quantum Energy Inc
OTC:QREE
|
US |
|
McBride PLC
F:10W
|
UK |
|
Etruscus Resources Corp
F:ERR
|
CA |
|
D
|
Digital Asset Acquisition Corp
NASDAQ:DAAQ
|
US |
|
Kasten Inc
OTC:KAST
|
US |
|
Beston Global Food Company Ltd
ASX:BFC
|
AU |
|
C
|
China Automotive Systems Inc
F:RYV
|
CN |
Wall St Price Targets
XLS Price Targets Summary
Xlife Sciences AG
Xlife Sciences AG
Wall Street analysts forecast XLS stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for XLS is 40.35 EUR with a low forecast of 39.95 EUR and a high forecast of 41.53 EUR.
Lowest Forecast
Price Target
39.95
EUR
141% Upside
Average Forecast
Price Target
40.35
EUR
143% Upside
Highest Forecast
Price Target
41.53
EUR
150% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XLS's stock price target?
Price Target
40.35
EUR
40.35
EUR
According to Wall Street analysts, the average 1-year price target for XLS is 40.35 EUR with a low forecast of 39.95 EUR and a high forecast of 41.53 EUR.
What is the Revenue forecast for Xlife Sciences AG?
Projected CAGR
-1%
-1%
Over the last 4 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 4 years is -1%.
